J. Craig Venter Institute, also known as JCVI, is a privately owned, US-based research institute founded in 1992, employing approximately 200 individuals. The institute specializes in biotechnology research, primarily focusing on genomic research.
On July 23, 2026, the J. Craig Venter Institute received a $200,000 grant from the St. Baldrick’s Foundation to advance childhood leukemia treatment. This funding supports research demonstrating a significant reduction in the replication and propagation of leukemia cells from a mouse model of MLL leukemia under BAF knockout conditions, evidenced by a decreased number of colonies and a shift in colony morphology from blast-like to more differentiated, mature cells.
Similar Companies
Subscribe for full access to J. Craig Venter Institute (JCVI)'s profile
Subscribe for full access to J. Craig Venter Institute (JCVI)'s products in full detail
Subscribe for full access to J. Craig Venter Institute (JCVI)'s revenue in full detail